Joined March 2015
565 Photos and videos
Pinned Tweet
Taking another extended Twitter hiatus. For consulting and advocacy-related inquiries, contact me via my website: annalegassie.com/. Be well, all.

1
3
An especially timely CMS update from my favorite health policy queen. I shouldn't need a new PA when switching jobs, plans, or providers. CC: @BCBSMA
BIG NEWS: CMS is finalizing that an approval granted through PA must be valid for as long as medically necessary to avoid disruptions in care in accordance with applicable coverage criteria, the patient’s medical history, and the treating provider’s recommendation.
1
4
308
Here's a new fun fact I learned today after more than 30 yrs of living w/a chronic illness: by simply changing docs @BCBSMA requires a new prior auth for a drug they've already approved I've been stable on for ~8 yrs while I'm already overdue for treatment and flaring. 1/
1
3
266
It probably seems like I'm just screaming into the Twitter abyss right now but I want a public record of this before I go to my state reps, the press, and pull every other lever available to me to get access to my treatment in a timely manner 7/ CC: @BCBSMA
2
2
147
I don't know what else to say other than that in the last 30 yrs @BCBSMA has cost me MONTHS of my life in treatment delays and lost productivity at work doing everything in their power not to pay for the treatments that my doctors have deemed best for me. I'm so exhausted. 8/8
1
1
1
108
Anna Evangeline (she/her) retweeted
Check out Anna Ellis, our Associate Director of Patient Affairs & Advocacy, in this @PatientWorthy article, where she shares her insights on how to ensure that patients’ perspectives are included in drug development. Read more here: bit.ly/3EMBJrk #RareDiseaseDay
3
8
375
Anna Evangeline (she/her) retweeted
Hear from our Associate Director of Patient Affairs & Advocacy, Anna Ellis, on her personal connection to the rare disease community and her commitment to ensuring that patients' voices are heard in drug development. #RareDiseaseDay
1
6
289
In the last week @BCBSMA tripled my copay on one medication and denied another Rx I’ve been on for 8 yrs citing dosing (they covered this dose for the ‘22 plan year) which I only found out at the time of refill. Y’all are exhausting.
1
1
186
Anna Evangeline (she/her) retweeted
The X4 team had a blast at the Boston @IDFCommunity Walk for PI this past weekend! We are so proud of this partnership and grateful for the opportunity to support the PI community.
1
3
Looking forward to attending NORD's Breakthrough Summit and presenting my first-ever poster: "The “Living With Chronic Neutropenia” Survey: Experiences and Preferences of People Living With Chronic Neutropenia." #patientadvocacy
X4 will be attending this year’s @RareDiseases (NORD) Rare Diseases & Orphan Product Breakthrough Summit where we will highlight lessons learned from a recent patient survey on living with #ChronicNeutropenia. Check out the full schedule here: bit.ly/3C0z7Fi
1
Anna Evangeline (she/her) retweeted
We're thrilled to have powerhouse advocates as faculty for our Advocacy Masterclass including @sixhips @tamikafelder @jennmcnary @CrzyCreoleMommy @BeingCharisBlog @hchang316 @LeilaniRGraham and @RarePOV! Apply now for the FALL 2022 course. ow.ly/q0Jn50KaYrs

7
11
Anna Evangeline (she/her) retweeted
Replying to @Medidata
@Medidata's new blog post explores the perspectives of #patientadvocacy experts @sixhips & @sreffey on how meaningful communication with patients can help #medicaldevice companies increase #clinicaltrial success rates. Read more: mdso.io/z0k
1
1
ICYMI: check out the #rheum panel I moderated as part of the inaugural #Automimmune Summit in October! @AutoimmuneAssoc
The #Rheum breakout at the #Autoimmune Summit featured powerhouse advocates and HCPs. The panels discussed the importance of setting boundaries, tips for condition management, clinical trials, and up and coming treatments. Tune in: ow.ly/RkCh50H4fjK
Anna Evangeline (she/her) retweeted
Today, our Senior Manager of Patient Affairs and Advocacy Operations, Anna Legassie, will join other #PatientAdvocacy leaders at a @MassMEDICouncil webinar to discuss the importance of patient engagement to successful #ClinicalTrials. Register here: bit.ly/3HOrkey
2
3
Looking forward to discussing the importance of #PatientEngagement to the success of medical device development with my dear friend @stales this Thu, 12/9!
2 Dec 2021
Join Medidata’s @stales for a discussion on improving patient experience and engagement in #medicaldevice #clinicaltrials. Learn about the patient journey, how it impacts trial design, and how technology can facilitate patient engagement. Register today: mdso.io/sdg
1
2
7